FTT 0.00% 0.5¢ factor therapeutics limited

Some random thoughts on valuation..., page-2

  1. 473 Posts.
    lightbulb Created with Sketch. 438
    chance of phase 2 success (80%)
    Thanks for that. A couple of quick questions:


    1. What's the basis for chance of phase 2 success being 80%? Based on historical averages, Phase II has the lowest success, with only 30.7% advancing to Phase III.

    2. What methodology have you used for the risk adjusted MC? Deal size multiplied by cumulative probabilities? While I may sounds critical on the % of ph 2 success, I am quite bullish here and I suspect the valuation would be higher if you did a DCF and then risked the NPV of the cash-flows as a takeover deal of $300m is extremely unlikely. Suspect they'd be looking to farm down some interest but retain a royalty on future sales. 

    https://hotcopper.com.au/data/attachments/1326/1326740-093b81212641572810ebff50aa6d2413.jpg

    Anyway, given Phase II has the lowest success, expect a major rerate on success in a few weeks time.


    Cheers, 


    5x8's

 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.